MEI Pharma Inc - Company Profile
Powered by
All the data and insights you need on MEI Pharma Inc in one report.
- Save hours of research time and resources with
our up-to-date MEI Pharma Inc Strategy Report
- Understand MEI Pharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
MEI Pharma Inc (MEI Pharma) focuses on the development of drugs for the treatment of cancer. Focus on R&D, strategic alliances and Lead drug: ME-344 are the major strengths of the company, even as operating loss carryforward is a cause for concern. It could find opportunities through growing incidences of cancer, acute myeloid leukemia, and rising healthcare expenditure in the US. However, it faces the challenges of competition, stringent regulations, and uncertain R&D outcomes.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer